11-1952170-A-C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_021134.4(MRPL23):c.184A>C(p.Asn62His) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021134.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL23 | NM_021134.4 | c.184A>C | p.Asn62His | missense_variant | Exon 3 of 5 | ENST00000397298.8 | NP_066957.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 1
GnomAD4 exome Cov.: 0
GnomAD4 genome Cov.: 1
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.184A>C (p.N62H) alteration is located in exon 3 (coding exon 3) of the MRPL23 gene. This alteration results from a A to C substitution at nucleotide position 184, causing the asparagine (N) at amino acid position 62 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at